Why do some IVF patients seek donor egg treatments at a different center than where they began? It could all come down to one simple question—one that our latest guest, Dr. Andy Toledo, CEO of Reproductive Biology Associates, frequently asks.

With over three decades in the field, Dr. Toledo shares his approach to counseling patients about donor eggs and third-party IVF without the hard sell.

Tune in as Dr. Toledo discusses:

- The key question he uses to convert IVF patients.

- How he counsels patients without being salesy.

- The evolving role of REIs as automation becomes more prevalent.

- Why pre-visit testing might not be as beneficial as it seems.

- Discovering the untapped market in embryo preservation.

If you’re looking to refine your donor and third-party programs, this episode is a must-listen.

How the heck can independent REIs compete against private equity giants in the fierce bidding war for fertility clinics?

Dr. Crystal Chan, Co-Owner of Markham Fertility, explains how, shedding light on the competitive landscape of reproductive medicine and female entrepreneurship.

Tune in to hear Dr. Chan share:

How many independent fertility practices are there now? Thanks to support from Mid Cap Advisors, Inside Reproductive Health has done the work and compiled a list of over 450 clinics across the USA, indicating if they’re independently owned, part of a fertility network, or part of an academic system. View the full list by visiting:

https://www.insidereproductivehealth.com/unitedstatesfertilitypracticeownershiplist2024

Why do insurance companies often have a much bigger advantage over fertility clinics? How do fertility clinics close the data gap with insurance companies?

In this week’s episode, JT Thompson, CFO of Inception Fertility, shares his expertise on leveraging business acumen to optimize operations and navigate the complexities of fertility care.

Tune in as JT discusses:

How does shaking hands on transfer day, and the day the news broke about Princess Diana’s death have to do with evidence- based reproductive medicine?

Professor Charles Kingsland,the chief medical officer of Care Fertility in the United Kingdom, with over 40 years of experience, reviews the spectrum of standards for evidence based medicine, and draws the line on what he thinks is fair.

Kingsland shares his own blending of evidence-based practices with personal rituals.

Tune in as Professor Charles Kingsland explores:

In today's episode, we delve into the crucial aspects of selling a fertility practice, egg bank, surrogacy agency, or pharmacy with two industry experts: Dr. Brijinder Minhas and Robert Goodman from MidCap Advisors. MidCap Advisors is a leading middle-market investment bank specializing in the sale and acquisition of fertility centers and other businesses.

Dr. Minhas, a former fertility practice owner and lab director, and Robert Goodman, a seasoned health systems administrator, share their extensive experience in facilitating successful transactions. They provide valuable insights into what buyers are looking for in today’s market and common pitfalls that can impact a sale.

What You’ll Learn:

Please note that this episode does not constitute legal advice or establish a consulting relationship. These insights are shared by seasoned professionals who have helped numerous practice owners navigate the complexities of selling their businesses.

Listen or read here.

Griffin

P.S. If you’re going to ASRM and think you might sell your practice, this is someone you want to talk to. Here’s Bob’s email.

PAY. FOR. BABY.

Fertility specialists sell a vital service that no one truly desires to purchase—a grueling IVF cycle—yet it's essential for achieving what patients desperately want: a baby. 

Nader AlSalim introduces an innovative model where patients pay only after successfully having a child, shifting the financial risk away from them. 

This episode is a must-listen for CEOs, practice owners, and revenue cycle managers looking to embrace this transformative approach.

Key Takeaways:

Enjoy this insightful conversation with Nader AlSalim and explore how your practice can adopt these innovative strategies.

Listen or read the transcript here.

Griffin

P.S. My suggestion--try to meet with Gaia at ASRM. Or Email them here.

What do you do if your lab staff sees the value in a new technology, but your business leadership views it as too much of an expense and not enough of an investment?

This is one of the many questions we explore with Dr. Jason Barritt, Chief Scientific Officer of Kindbody. Dr. Barritt provides an inside look at how he leverages innovative ideas to make fertility care more accessible and affordable at scale.

With Dr. Barritt, we dive into:

What are the most important KPIs for your fertility clinics? How do you define them?

We explore that with today's guest, TJ Farnsworth, CEO of Inception Fertility, as he shares his best practices for establishing KPIs to obtain reliable data, and how to use it effectively.

Tune in as TJ provides his perspective on:

Back as CEO.

Gina Bartasi, returning CEO of Kindbody, provides a look at the strategies behind Kindbody's recent success and their vision for the future. Gina talks about Kindbody’s announcement of profitability, new initiatives, and lessons learned by the company.

Are you willing to fight for what’s necessary to lead the fertility innovation revolution, or will you be a replaceable part when the new system emerges?

Cynthia Hudson, veteran embryologist and scientific advisor, gives an earnest look at the current fertility system, the driving forces replacing it, and what that means for today's REIs.

Tune in to hear Ms. Hudson discuss:

The views and thoughts expressed by the guest are their own and do not mean they are the views and thoughts of their employer.